Open the mobile version, with barcode scanning
Class I Terminated

Limbrel500 (flavocoxid and citrated zinc bisglycinate) 500 mg/50 mg capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsdale, AZ 85253; Manufactured by: Cornersto…

Why: Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.

Company
Primus Pharmaceuticals, Inc.
Scottsdale, AZ, United States
Reported
Feb 21, 2018
Recall started
Jan 26, 2018
Ended
Jul 16, 2019
Where sold
Nationwide in the USA.
Amount
160,489 bottles
Full product description
Limbrel500 (flavocoxid and citrated zinc bisglycinate) 500 mg/50 mg capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsdale, AZ 85253; Manufactured by: Cornerstone Research and Development, Ogden, UT 84404, NDC 68040-606-16.
Lots / codes affected
All lots within expiry.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.